Remarkably, a critical feature of the metabolic disorders for ACLF was the disruption of lipid and fatty acid metabolism, manifesting as the upregulation of genes related to the peroxisome proliferator-activated receptor (PPAR) and mTOR signaling pathways [17]. This evidence concerns the gene MTOR and metabolic disease.